Karolinska Development AB

Historique de performance de Karolinska Development AB

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Karolinska Development AB

Co-initiés de Karolinska Development AB

• 5AM Co-Investors IV, L.P.Aprea Therapeutics, Inc.
• 5AM Opportunities I (GP), LLCAprea Therapeutics, Inc.
• 5AM Opportunities I, L.P.Aprea Therapeutics, Inc.
• 5AM Partners IV, LLCAprea Therapeutics, Inc.
• 5AM Ventures IV, L.P.Aprea Therapeutics, Inc.
• Abrahmsen Lars B.Aprea Therapeutics, Inc.
• Attar Eyal C.Aprea Therapeutics, Inc.
• BIZZARI JEAN-PIERREAprea Therapeutics, Inc.
• Christenson JohanAprea Therapeutics, Inc.
• Coiante Scott MAprea Therapeutics, Inc.
• DIEKMAN JOHN DAprea Therapeutics, Inc.
• Duey MarcAprea Therapeutics, Inc.
• Gilad OrenAprea Therapeutics, Inc.
• Green JeremyAprea Therapeutics, Inc.
• Grissinger MichaelAprea Therapeutics, Inc.
• Gruia GabrielaAprea Therapeutics, Inc.
• Hamill John P.Aprea Therapeutics, Inc.
• HealthCap VII GP S.A.Aprea Therapeutics, Inc.
• HealthCap VII, L.P.Aprea Therapeutics, Inc.
• HENNEMAN JOHN B IIIAprea Therapeutics, Inc.
• Hepple JonathanAprea Therapeutics, Inc.
• KCIF Co-Investment Fund KBAprea Therapeutics, Inc.
• KDev Investments ABAprea Therapeutics, Inc.
• Kelly Michael AaronAprea Therapeutics, Inc.
• Korbel Gregory AlanAprea Therapeutics, Inc.
• Magni GuidoAprea Therapeutics, Inc.
• Mirza Nadeem Q.Aprea Therapeutics, Inc.
• Namouni FouadAprea Therapeutics, Inc.
• Pamukcu RifatAprea Therapeutics, Inc.
• PARMAR KUSHAprea Therapeutics, Inc.
• Peters RichardAprea Therapeutics, Inc.
• Redmile Group, LLCAprea Therapeutics, Inc.
• ROCKLAGE SCOTT MAprea Therapeutics, Inc.
• SCHADE CHRISTIAN SAprea Therapeutics, Inc.
• Schwab Andrew J.Aprea Therapeutics, Inc.
• Seizinger Bernd R.Aprea Therapeutics, Inc.
• Versant Affiliates Fund V, L.P.Aprea Therapeutics, Inc.
• Versant Ophthalmic Affiliates I, L.P.Aprea Therapeutics, Inc.
• Versant Vantage I GP-GP, LLCAprea Therapeutics, Inc.
• Versant Vantage I GP, L.P.Aprea Therapeutics, Inc.